- Page 1 and 2: LEGIONELLA AND THE PREVENTION OF LE
- Page 3 and 4: LEGIONELLA AND THE PREVENTION OF LE
- Page 5 and 6: Foreword Legionellosis is a collect
- Page 7: Contents Foreword . . . . . . . . .
- Page 11 and 12: Chapter 9 Disease surveillance and
- Page 13 and 14: Tables Table 1.1 Main characteristi
- Page 15 and 16: Figure 8.1 Visible biofilm on inter
- Page 17 and 18: Acknowledgements The World Health O
- Page 19 and 20: • John Newbold, Health and Safety
- Page 21 and 22: Executive summary Legionellosis is
- Page 23 and 24: • Health-care facilities — Chap
- Page 25 and 26: Chapter 1 Legionellosis Britt Horne
- Page 27 and 28: Legionnaires’ disease is often in
- Page 29 and 30: 1.1.2 Pontiac fever Symptoms Pontia
- Page 31 and 32: Table . Extrapulmonary nfect ons ca
- Page 33 and 34: Proteins produced by the body’s i
- Page 35 and 36: Aspiration may occur in patients wi
- Page 37 and 38: Table . R sk factors for Legionella
- Page 39 and 40: In the outbreak of Legionnaires’
- Page 41 and 42: Table . Potent al treatments for d
- Page 43 and 44: 1.4.2 Species and serogroups associ
- Page 45 and 46: Other causes of infection In Europe
- Page 47 and 48: The interaction of virulent legione
- Page 49 and 50: 1.5.2 Surface structures involved i
- Page 51 and 52: 1.5.4 Host defence The host defence
- Page 53 and 54: Chapter 2 Ecology and environmental
- Page 55 and 56: L. pneumophila is thermotolerant an
- Page 57 and 58: 2.2.3 Environmental factors and vir
- Page 59 and 60:
Figure 2.1 Biofilm formation Biofil
- Page 61 and 62:
2.4 Sources of Legionella infection
- Page 63 and 64:
Chapter 3 Approaches to risk manage
- Page 65 and 66:
Table . Cool ng tower outbreaks Fac
- Page 67 and 68:
Even when a source reaches a state
- Page 69 and 70:
The WSP should be prepared in conju
- Page 71 and 72:
Identify control measures Control m
- Page 73 and 74:
F gure . Dec mal reduct on t mes fo
- Page 75 and 76:
Method Advantages D sadvantages Dos
- Page 77 and 78:
Validate effectiveness of water saf
- Page 79 and 80:
• clear statements of responsibil
- Page 81 and 82:
Chapter 4 Potable water and in-buil
- Page 83 and 84:
The remainder of this chapter provi
- Page 85 and 86:
4.3.1 Document and describe the sys
- Page 87 and 88:
Construction materials — risk fac
- Page 89 and 90:
Where temperature controls (discuss
- Page 91 and 92:
4.4.2 Monitor control measures This
- Page 93 and 94:
Chapter 5 Cooling towers and evapor
- Page 95 and 96:
5.1.1 Cross-flow cooling towers As
- Page 97 and 98:
water treatments (including chemica
- Page 99 and 100:
5.3 System assessment This section
- Page 101 and 102:
Spray drift — risk factors Even w
- Page 103 and 104:
The section on control measures for
- Page 105 and 106:
• periodic or continuous bleed-of
- Page 107 and 108:
Box . Po nts to be noted when clean
- Page 109 and 110:
In certain circumstances, samples m
- Page 111 and 112:
Table . Example documentat on for m
- Page 113 and 114:
Chapter 6 Health-care facilities Ma
- Page 115 and 116:
For 1999 and 2000, a total of 384 c
- Page 117 and 118:
6.3 System assessment This section
- Page 119 and 120:
Table . Type of colon zat on of wat
- Page 121 and 122:
6.4.1 Identify control measures Thi
- Page 123 and 124:
6.5.1 Prepare management procedures
- Page 125 and 126:
Until the situation is under contro
- Page 127 and 128:
Chapter 7 Hotels and ships Roisin R
- Page 129 and 130:
F gure . Detected and reported case
- Page 131 and 132:
Table . Rev ew of outbreaks (more t
- Page 133 and 134:
7.2 Water safety plan overview WSPs
- Page 135 and 136:
The risk of legionellosis is increa
- Page 137 and 138:
Kingdom to 66% in Spain (Starlinger
- Page 139 and 140:
Agency, Legionella Section, United
- Page 141 and 142:
Given the complexity of distributio
- Page 143 and 144:
Chapter 8 Natural spas, hot tubs an
- Page 145 and 146:
Spas “Natural spa”, denotes fac
- Page 147 and 148:
Rare cases of Legionnaires’ disea
- Page 149 and 150:
Process step P pework Water n hot t
- Page 151 and 152:
Hosepipes may sometimes be used to
- Page 153 and 154:
Hot tubs that are not effectively d
- Page 155 and 156:
Nutrients — control measures Bath
- Page 157 and 158:
Various additives may also be used
- Page 159 and 160:
• descriptions of any significant
- Page 161 and 162:
Table . Examples of m crob olog cal
- Page 163 and 164:
Chapter 9 Disease surveillance and
- Page 165 and 166:
Exposure histories allow cases to b
- Page 167 and 168:
F gure . Invest gat ng a s ngle cas
- Page 169 and 170:
Box . (cont nued) Since the incepti
- Page 171 and 172:
Country United Kingdom All reported
- Page 173 and 174:
F gure . Annual reported cases, - 0
- Page 175 and 176:
Training opportunities Trainees in
- Page 177 and 178:
Box . Example of terms of reference
- Page 179 and 180:
ecause doing anything more could un
- Page 181 and 182:
9.4 Case studies This section descr
- Page 183 and 184:
9.4.4 Concrete batcher process on a
- Page 185 and 186:
Chapter 10 Regulatory aspects David
- Page 187 and 188:
• validation of the effectiveness
- Page 189 and 190:
• operating conditions, such as t
- Page 191 and 192:
10.4.6 Outbreak investigation and n
- Page 193 and 194:
hot water (e.g. health-care facilit
- Page 195 and 196:
General prevent on Country DW Wp SB
- Page 197 and 198:
Country General prevent on DW Wp SB
- Page 199 and 200:
Chapter 11 Laboratory aspects of Le
- Page 201 and 202:
• detection of the bacterium in t
- Page 203 and 204:
Method Sens t v ty (%) PCR • Rapi
- Page 205 and 206:
11.2.2 Detecting Legionella antigen
- Page 207 and 208:
DFA has been used successfully with
- Page 209 and 210:
• Serologic testing can be used f
- Page 211 and 212:
Although not all strains can be rel
- Page 213 and 214:
Generally, any water source that ma
- Page 215 and 216:
During outbreak investigations, swa
- Page 217 and 218:
• other Legionella species that d
- Page 219 and 220:
Appendix 1 Example of a water syste
- Page 221 and 222:
Weekly water system check list Week
- Page 223 and 224:
Appendix 2 Example of a 2-week foll
- Page 225 and 226:
Travel Work/travel in the UK: ❑ Y
- Page 227 and 228:
Checklist of local places Health/sp
- Page 229 and 230:
Appendix 3 Example of a national su
- Page 231 and 232:
Strictly Confidential 2 Hospital Ac
- Page 233 and 234:
Glossary aerobic bacteria Bacteria
- Page 235 and 236:
health-care acquired Legionellosis
- Page 237 and 238:
surveillance The process of systema
- Page 239 and 240:
References Abu KY, Eisenstein BI, E
- Page 241 and 242:
Barbaree JM et al. (1987). Protocol
- Page 243 and 244:
Blatt SP et al. (1994). Legionnaire
- Page 245 and 246:
Byrne B, Swanson MS (1998). Express
- Page 247 and 248:
Crespi S (1993). Legionella y legio
- Page 249 and 250:
Edelstein PH (1982b). Comparative s
- Page 251 and 252:
Falguera M et al. (2001). Nonsevere
- Page 253 and 254:
Gaia V et al. (2003). Sequence-base
- Page 255 and 256:
Hayden RT et al. (2001). Direct det
- Page 257 and 258:
Ingram JG, Plouffe JF (1994). Dange
- Page 259 and 260:
Ko KS et al. (2003). Molecular evol
- Page 261 and 262:
Loret JF et al. (2003). Comparison
- Page 263 and 264:
McEvoy M et al. (2000). A cluster o
- Page 265 and 266:
Olaechea PM et al. (1996). A predic
- Page 267 and 268:
Regan CM et al. (2003). Outbreak of
- Page 269 and 270:
Schulze-Robbecke R, Rodder M, Exner
- Page 271 and 272:
Surman SB, Morton LHG, Keevil CW (1
- Page 273 and 274:
Tully M, Williams A, Fitzgeorge RB
- Page 275 and 276:
Welti M et al. (2003). Development